Safety and Accuracy of Sentinel Lymph Node Biopsy Alone in Clinically Node-Positive Patients Undergoing Upfront Surgery for Invasive Breast Cancer: A Systematic Review

Landmark trials (Z0011 and AMAROS) have demonstrated that axillary lymph node dissection (ALND) can be safely omitted in patients with breast cancer and 1–2 positive sentinel nodes. Extrapolating from these and other cardinal studies such as NSABP B-04, guidelines state that patients with 1–2 needle...

Descripción completa

Detalles Bibliográficos
Autores principales: Lovrics, Olivia, Tao, Brendan, Parvez, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047769/
https://www.ncbi.nlm.nih.gov/pubmed/36975448
http://dx.doi.org/10.3390/curroncol30030235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047769/
https://www.ncbi.nlm.nih.gov/pubmed/36975448
http://dx.doi.org/10.3390/curroncol30030235

Ejemplares similares